Three new doctoral training programmes involving the University of Manchester are set to train more than 90 PhD researchers in biotechnology, with a focus on bridging the gap between laboratory discoveries and real-world industrial applications, according to a university announcement.
The programmes — BioProcess, BioAID and CODE-M — are designed to equip the next generation of scientists with the multidisciplinary skills needed to translate biotechnology breakthroughs into scalable processes for sectors including pharmaceuticals, sustainable manufacturing, health, food and the environment.
“Tomorrow’s biotechnology needs multidisciplinary researchers, able to connect biology and chemistry with engineering, AI, computation and data science,” the university said in a statement.
BioProcess focuses on developing expertise in biocatalysis and protein engineering, covering the full pipeline from enzyme discovery and AI-enabled optimisation through to industrial scale-up. Students on this programme are based across the universities of Manchester, York and Bristol and are required to spend at least three months on a company placement.
BioAID, led by Queen’s University Belfast with co-leads including Professor Sam Hay from the Manchester Institute of Biotechnology, along with the universities of Edinburgh and Bristol, will train researchers in AI-empowered biocatalysis. The programme aims to address critical challenges in developing sustainable solutions for pharmaceuticals, agri-tech and clean manufacturing.
CODE-M is led by the University of Manchester in partnership with the University of Liverpool and focuses on engineering microbial cells and communities to tackle challenges spanning health, clean growth, food systems and the environment.
Together, the three programmes will fund more than 90 PhD places, the university reported.
“It's about giving researchers the expertise to turn breakthroughs in biocatalysis and protein engineering into technologies that can work at industrial scale,” said Professor Sam Hay, Professor of Biophysical Chemistry at the Manchester Institute of Biotechnology.
The cohort-based training model emphasises strong links between universities and industry, with the aim of producing researchers who can connect biology and chemistry with engineering, computation and data science, while understanding the changes required when a process moves from the laboratory towards manufacture.
For students considering a PhD in biotechnology or related fields, these programmes represent funded opportunities that combine academic research with industrial experience. The placement component in BioProcess, for example, offers direct exposure to commercial R&D environments, which can be valuable for those planning careers in the biotech industry.
The announcement comes as the biotechnology sector increasingly demands researchers who can work across disciplinary boundaries, a trend that is shaping doctoral training programmes at universities worldwide.